Wearable Sensors Measure Ankle Joint Changes of Patients with Parkinson’s Disease before and after Acute Levodopa Challenge
Table 1
Clinical characteristics of participants.
HC
PD
N
30
29
Age
62.7 ± 6.7
65.7 ± 10.2
0.185
Height (cm)
164 ± 4.9
167 ± 8.0
0.180
Weight (kg)
61.8 ± 9.6
66.2 ± 9.5
0.082
BMI (M)
22.9
23.8
0.111
Male (%)
16 (53.3)
18 (62.1)
0.497
Shoe size (M)
7
8
0.060
MoCA
24.4 ± 0.8
24.0 ± 1.1
0.080
Duration of PD (years)
6.4 ± 4.6
Hoehn–Yahr stage
2.7 ± 0.7
UPDRS III total scores in OFF state
35.8 ± 16.9
UPDRS III improvement scores
15.1 ± 9.9
UPDRS III improvement rate (%)
39.8 ± 15.3
Data are shown as mean ± SD and median. M: median. BMI: body mass index. MoCA: montreal cognitive assessment. UPDRSIII: Unified Parkinson’s disease rating scale part 3.
